Gomberg-Maitland M - Search Results

1

Selective serotonin reuptake inhibitors and the incidence and outcome of pulmonary hypertension.

Shah SJ, Gomberg-Maitland M, Thenappan T, Rich S. Shah SJ, et al. Chest. 2009 Sep;136(3):694-700. doi: 10.1378/chest.08-2823. Epub 2009 Apr 6. Chest. 2009. PMID: 19349384

2

Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension.

Gomberg-Maitland M, Tapson VF, Benza RL, McLaughlin VV, Krichman A, Widlitz AC, Barst RJ. Gomberg-Maitland M, et al. Am J Respir Crit Care Med. 2005 Dec 15;172(12):1586-9. doi: 10.1164/rccm.200505-766OC. Epub 2005 Sep 8. Am J Respir Crit Care Med. 2005. PMID: 16151039 Clinical Trial.

3

Efficacy and safety of sildenafil added to treprostinil in pulmonary hypertension.

Gomberg-Maitland M, McLaughlin V, Gulati M, Rich S. Gomberg-Maitland M, et al. Am J Cardiol. 2005 Nov 1;96(9):1334-6. doi: 10.1016/j.amjcard.2005.06.083. Epub 2005 Sep 16. Am J Cardiol. 2005. PMID: 16253609 Clinical Trial.

4

Relative adrenal insufficiency in severe congestive heart failure with preserved systolic function: a case report.

Lovelock JD, Coslet S, Johnson M, Rich S, Gomberg-Maitland M. Lovelock JD, et al. J Cardiovasc Med (Hagerstown). 2007 Sep;8(9):754-7. doi: 10.2459/JCM.0b013e328011c256. J Cardiovasc Med (Hagerstown). 2007. PMID: 17700413

5

A USA-based registry for pulmonary arterial hypertension: 1982-2006.

Thenappan T, Shah SJ, Rich S, Gomberg-Maitland M. Thenappan T, et al. Eur Respir J. 2007 Dec;30(6):1103-10. doi: 10.1183/09031936.00042107. Epub 2007 Sep 5. Eur Respir J. 2007. PMID: 17804449 Free article.

6

Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer.

Archer SL, Gomberg-Maitland M, Maitland ML, Rich S, Garcia JG, Weir EK. Archer SL, et al. Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H570-8. doi: 10.1152/ajpheart.01324.2007. Epub 2007 Dec 14. Am J Physiol Heart Circ Physiol. 2008. PMID: 18083891 Free article. Review.

7

United States validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR).

Gomberg-Maitland M, Thenappan T, Rizvi K, Chandra S, Meads DM, McKenna SP. Gomberg-Maitland M, et al. J Heart Lung Transplant. 2008 Jan;27(1):124-30. doi: 10.1016/j.healun.2007.10.004. J Heart Lung Transplant. 2008. PMID: 18187098

8

Association of serum creatinine with abnormal hemodynamics and mortality in pulmonary arterial hypertension.

Shah SJ, Thenappan T, Rich S, Tian L, Archer SL, Gomberg-Maitland M. Shah SJ, et al. Circulation. 2008 May 13;117(19):2475-83. doi: 10.1161/CIRCULATIONAHA.107.719500. Epub 2008 May 5. Circulation. 2008. PMID: 18458173

9

Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension.

Hampole CV, Mehrotra AK, Thenappan T, Gomberg-Maitland M, Shah SJ. Hampole CV, et al. Am J Cardiol. 2009 Sep 15;104(6):868-72. doi: 10.1016/j.amjcard.2009.05.016. Am J Cardiol. 2009. PMID: 19733726

10

Carbon monoxide diffusing capacity and mortality in pulmonary arterial hypertension.

Chandra S, Shah SJ, Thenappan T, Archer SL, Rich S, Gomberg-Maitland M. Chandra S, et al. J Heart Lung Transplant. 2010 Feb;29(2):181-7. doi: 10.1016/j.healun.2009.07.005. Epub 2009 Sep 26. J Heart Lung Transplant. 2010. PMID: 19783169

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters